一项随机研究和一项扩展研究,对边缘性人格障碍患者进行布雷克斯皮普拉的研究
Brian Rothman1, Claudette Brewer1, Denise Chang1
1Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA.
Acta neuropsychiatrica
|November 19, 2024
概括
布雷克西普拉在第二阶段试验中没有显著改善边缘性人格障碍 (BPD) 症状. 虽然没有满足主要终点,但由于潜在的疗效信号和可管理的安全性概况,建议对BPD的布雷克斯皮普拉进行进一步的研究.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 边界性人格障碍 (BPD) 目前缺乏经批准的药物治疗方法.
- 布雷克西普拉是一种非典型的抗精神病药物,在各种精神疾病中具有潜在的应用.
研究的目的:
- 评估布雷克斯皮普拉在治疗成年人BPD时的疗效,安全性和耐受性.
- 与安慰剂相比,评估布雷克斯皮普拉对BPD症状严重性的影响.
主要方法:
- 一个随机的,双盲的,安慰剂控制的第2期研究,随后进行了开放式扩展.
- 患有BPD的成人门诊患者接受了灵活剂量的布雷克西普拉 (2-3毫克/天) 或安慰剂11周.
- 主要结局是Zanarini评分表对BPD总分的变化.
主要成果:
- 布雷克西普拉在主要终点 (p = 0.24) 上没有显示出与安慰剂的统计学上显著差异.
- 在主要终点以外的时间点观察到布雷克斯皮普拉的一些数值优势.
- 最常见的治疗出现的不良事件是 akathisia;在延长研究中,整体不良事件似乎是暂时的.
结论:
- 这项研究没有满足BPD治疗中布雷克斯皮普拉的初级终点.
- 鉴于观察到的疗效信号和其安全性概况,需要对布雷克斯皮普拉对BPD进行进一步的研究.
相关概念视频
01:25Borderline Personality Disorder
36
Borderline Personality Disorder is a complex and multifaceted mental health condition characterized by pervasive instability in interpersonal relationships, self-image, emotions, and impulse control. This instability manifests in extreme emotional reactions, fear of abandonment, and self-destructive behaviors. The disorder significantly impacts daily functioning, often leading to distress in both personal and professional domains.
Genetic and Environmental Contributions
Borderline Personality...
Genetic and Environmental Contributions
Borderline Personality...
36
01:16Crossover Experiments
2.7K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.7K
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:30Bipolar Disorder
56
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
56
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
121
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
121
01:11Blinding
2.4K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.4K